Core business revenue of radiology and pathology up by 14.7 per cent y-o-y
Krsnaa Diagnostics has announced the results for the first quarter ending September 30, 2022.
H1 FY2023 performance highlights
- Revenue from operations registered a revenue of 2,358 million
- Core business of radiology and pathology registered a revenue of Rs 2,352 million, an increase of 7 per cent on y-o-y basis
- COVID-19 revenues decreased by 4 per cent to Rs 6 million
- EBITDA* of 593 million, with margins of 25.1 per cent
- Profit after tax of Rs 296 million, with margins of 5 per cent
* EBITDA is excluding CSR and ESOP expenses
Commenting on the Business, Pallavi Bhatevara, Managing Director, Krsnaa Diagnostics said, “Krsnaa Diagnostics has always been at the forefront when it comes to serving the healthcare needs of our society. Today the company is the largest premium quality integrated diagnostics service provider in India with 2,000+ locations with accessible and affordable rates. In line with our growth strategy, Krsnaa Diagnostic has operationalised 10 pathology labs out of 24 and 126 collection centers out of 190 in Himachal Pradesh. In the state of Punjab, the company has operationalised 20 CT scanners out of 25, 5 MRI machines out of 6, 18 pathology labs out of 30 including 1 referral laboratory and 95 collection centers. This amounts to the completion of 88 per cent of the project as of date.
“Considering the rising demand for diagnostics services and to cater to the remotest parts of the country, Krsnaa Diagnostics has entered selected markets through the franchise and in addition plan to launch 600 collection centers across India, providing services at attractive prices. This growth will strengthen the company’s footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan especially in tier 2 and 3 cities. The centers are well equipped to offer specialised services in genetics, genomics and molecular diagnostics, along with the core investigations of biochemistry, serology and histopathology. The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health and cancer care. With continued expansion to new geographies and diversification, KRSNAA continues to build its strong fundamentals for long term”, she added.
- Advertisement -